News

IMG GmbH was certified by the Tübingen Regional Council in accordance with Article 111 of Directive 2001/83/EC and acquired a GDP certificate under the number DE_BW_05_GDP_2024_0005 on May 23, 2024.

IMG GmbH has expanded its range of available medicines and added a new drug, Methoxsalen G.L.Ph. 20 µg/ml, pack size 50 ampoules, aktive ingredient 8-Methoxypsoralen, for the treatment of oncological diseases using the photopheresis (also extracorporeal photopheresis, ECP) procedure.